Pneumonia vaccine
  • The Drug Controller General of India (DCGI) has given approval to India’s first fully indigenously developed vaccine against pneumonia ‘Pneumococcal Polysaccharide Conjugate Vaccine’.
  • The vaccine has been developed by the Pune-based firm Serum Institute of India.
  • After reviewing the phase I, II, and III clinical trial data for vaccines, submitted by Serum Institute, the drug regulator gave the market approval to the homemade vaccine.
  • Pneumococcal Polysaccharide Conjugate Vaccine is the first indigenously developed vaccine in the field of pneumonia.

Leave a Reply

Your email address will not be published. Required fields are marked *